Client News

InflaRx to Report Full Year 2025 Results on March 19, 2026

Galimedix Therapeutics to present promising pre-clinical data with next generation oral amyloid beta aggregation modulator at AD/PD™ 2026 Conference

Cellbox Solutions closes first tranche of Series A financing and appoints new CBO/CFO to accelerate international growth

Formycon AG publishes preliminary figures for the 2025 fiscal year

T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors

Secarna Pharmaceuticals and Curie.Bio Expand Existing Partnership

NVision Establishes First Strategic European Hub at University of Cambridge to Advance Clinical Translation of Quantum-Enhanced Metabolic MRI

InflaRx Announces Participation in the Leerink Partners Global Healthcare Conference

AFYREN raises €7 million through share capital increase to support its industrial deployment

Darwin AG Announces Preliminary Group Revenue for 2025 and Confirms Strategic Growth Trajectory